NRT Smoking Cessation Aids in
Country Report
Executive Summary
Oct 2017PROSPECTS
Sales growth slows due to a falling number of smokers
Over the review period smokers in Croatia faced rising tobacco prices and bans on smoking in public places, thus making the habit both difficult and costly to maintain. Thanks also to public health campaigns discouraging smoking, this led to an increase in the number of smokers looking to kick the habit.
New legislation serves as a further attack on the tobacco industry
Croatia had long postponed the ratification of EU directive 2014/40 on tobacco use, with this risking punishment from the European Commission. However, in mid-2017, the new law was passed, introducing graphic health warnings to cover two thirds of cigarette packs, along with a written warning.
No threat from prescription medicines
Unlike some other OTC categories, NRT smoking cessation aids face no competition from prescription medicines. Although Champix from Pfizer has been licensed in Croatia via the centralised procedure of the EMA (European Medicines Agency), it is not available, thus leaving space for the Nicorette and Niquitin brands.
COMPETITIVE LANDSCAPE
Competitive landscape remains stable
The competitive landscape in NRT smoking cessation aids remained stable in 2017, with very little change having been witnessed for many years. There are only two companies present, Pfizer Croatia, which sells Johnson & Johnson’s Nicorette brand, and GlaxoSmithKline, which sells Niquitin CQ, owned by Perrigo.
Nicorette the leading brand
Thanks to the first mover advantage, Nicorette enjoys a comfortable lead, commanding nearly two thirds of value sales, with Niquitin accounting for the remainder. Nicorette’s share has been slowly falling, mostly due to Niquitin being focused on NRT gum, which is growing in popularity.
Your Recently Viewed Reports
NRT Smoking Cessation Aids in Croatia
Samples (FAQs about samples):
Delivery: Files are delivered directly into your account within a few minutes of purchase.
Overview
Discover the latest market trends and uncover sources of future market growth for the NRT Smoking Cessation Aids industry in Croatia with research from Euromonitor's team of in-country analysts.
Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.
If you're in the NRT Smoking Cessation Aids industry in Croatia, our research will save you time and money while empowering you to make informed, profitable decisions.
The NRT Smoking Cessation Aids in Croatia market research report includes:
- Analysis of key supply-side and demand trends
- Detailed segmentation of international and local products
- Historic volumes and values, company and brand market shares
- Five year forecasts of market trends and market growth
- Production, imports by origin, exports by destination
- Robust and transparent market research methodology, conducted in-country
Our market research reports answer questions such as:
- What is the market size of NRT Smoking Cessation Aids in Croatia?
- What are the major brands in Croatia?
- How have tobacco bans affected the sales of NRT Smoking Cessation Aids?
Why buy this report?
- Gain competitive intelligence about market leaders
- Track key industry trends, opportunities and threats
- Inform your marketing, brand, strategy and market development, sales and supply functions
This industry report originates from Passport, our Consumer Health market research database.
Related Reports
- Consumer Health in Hong Kong, China | Nov 2019
- Bayer in Consumer Health | Nov 2019
- Johnson & Johnson in Consumer Health | Nov 2019
- Consumer Health in Taiwan | Oct 2019
- Vitamins and Dietary Supplements in Latin America | Oct 2019